[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hypermetropia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hypermetropia":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100657382","the-emmetropization-via-accommodation-eva---ii-study-100657382",false,"NCT07838597","The Emmetropization Via Accommodation (EVA) - II Study","EVA-II","Inclusion Criteria:\n\n* Signed parental permission and HIPAA authorization and willingness to comply with study procedures.\n* Infant 13-19 weeks of age at baseline.\n* Either sex and any race or ethnicity.\n* Good general health based on parent-provided history, normal pregnancy and delivery without serious complications, and birthweight \\>2500 g.\n* Mean MEM accommodative lag \\>+1.25 D based on three measurements throughout the baseline examination.\n* Cycloplegic spherical-equivalent hyperopia ≥+3.50 D in one or both eyes.\n\nExclusion Criteria:\n\n* Astigmatism \\>2.00 D in either eye.\n* Anisometropia \\>1.50 D spherical equivalent.\n* Strabismus.\n* Previous difficulty with pupil dilation.\n* Cardiac, liver, asthma, or other respiratory disease.\n* Ocular disease\u002Fabnormality, prior intraocular surgery, retinal detachment, optic nerve hypoplasia, malformation of the eye, cortical visual impairment, or active ocular inflammation.\n* Hydrocephalus, Down syndrome, cerebral palsy, severe developmental delay, or seizure disorder.\n* A condition preventing spectacle wear for the study duration (e.g., plagiocephaly).","ALL","13 Weeks","19 Weeks",{"count":20,"type":21},52,"ESTIMATED","INTERVENTIONAL",[24],"NA","To determine if wearing a novel treatment during a 15-month period will enhance emmetropization in 4-month-old infants who have demonstrated poor ocular accommodation (eye focusing).",[27,28,29],"Hyperopia","Farsightedness","Hypermetropia",[31],"emmetropization","NOT_YET_RECRUITING","2026-09-17",{"date":35,"type":36},"2026-09-24","ACTUAL",{"date":38,"type":21},"2027-04-01",{"date":40,"type":21},"2032-06-30",{"name":42,"class":43},"Ohio State University","OTHER"]